Paul I. Pisacane

<b>Endocytosis and Sorting of ErbB2 and the Site of Action of Cancer Therapeutics Trastuzumab and Geldanamycin</b>

Cary D. Austin, Ann M. De Mazière, Paul I. Pisacane et al. · Molecular Biology of the Cell · 2004 · 486 citations · Full text

Pathology, Surface Erbb2, Cancer Biology +20

Inhibition of HER2/neu (erbB-2) and mitogen-activated protein kinases enhances tamoxifen action against HER2-overexpressing, tamoxifen-resistant breast cancer cells.

Hirokazu Kurokawa, Anne E.G. Lenferink, Jean F. Simpson et al. · PubMed · 2000 · 367 citations

Tumor Biology, Breast Oncology, Endocrine-related Cancer +15

Targeting cyclooxygenase 2 and HER-2/neu pathways inhibits colorectal carcinoma growth

Moss Mann, Hongmiao Sheng, Jinyi Shao et al. · Gastroenterology · 2001 · 181 citations

Tumor Biology, Oncology, Medicine +7

IL-13 protects mice from lipopolysaccharide-induced lethal endotoxemia: correlation with down-modulation of TNF-alpha, IFN-gamma, and IL-12 production

Tony Muchamuel, Satish Menon, Paul I. Pisacane et al. · The Journal of Immunology · 1997 · 162 citations · Full text

Biologic effects of heregulin/neu differentiation factor on normal and malignant human breast and ovarian epithelial cells

Zuleima Aguilar, Robert W. Akita, Richard S. Finn et al. · Oncogene · 1999 · 144 citations

Breast Oncology, Medicine, Pathology +11